Skip to main content
. Author manuscript; available in PMC: 2016 Oct 3.
Published in final edited form as: Cancer Causes Control. 2010 Jun 23;21(10):1545–1557. doi: 10.1007/s10552-010-9583-9

Table 4.

Carrier risk of VEGF haplotypes for disease recurrence and disease-related mortality

VEGF Haplotype (−2578, −1154, −634) Frequency # Carriers (%) HRR (95% CI) p-value HRD (95% CI) p-value
AGGtwo low-expressing alleles 0.165 128 (0.31) 0.62 (0.39–1.00) 0.05 0.70 (0.46–1.05) 0.09
CGCthree high-expressing alleles 0.353 242 (0.58) 0.91 (0.61–1.36) 0.65 0.98 (0.68–1.42) 0.93
AAGtwo low-expressing alleles 0.248 199 (0.48) 0.88 (0.59–1.31) 0.53 0.73 (0.51–1.05) 0.09
CGGtwo high-expressing alleles 0.198 145 (0.35) 1.58 (1.06–2.35) 0.03 1.68 (1.16–2.42) 0.01

HRR hazard ratio for disease recurrence, HRD hazard ratio for disease-related mortality